InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Schroeder Theodore R, Former Chief Executive Officer. Officer active across 2 companies, notably Nabriva Therapeutics plc. Cumulatively, 46 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €98k. Activity tracked since 30 April 2021. The latest transaction was disclosed on 16 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Schroeder Theodore R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
21,000 shares0Common StockSEC:0000950170-25-054886:0
431 shares@ US$1.500.3% of flowOrdinary SharesSEC:0001104659-23-008854:0
11 shares@ US$1.300.0% of flowOrdinary SharesSEC:0001104659-23-002821:0
5 shares@ US$1.890.0% of flowOrdinary SharesSEC:0001104659-23-001008:0
9 shares@ US$2.020.0% of flowOrdinary SharesSEC:0001104659-22-125506:0
5 shares@ US$2.250.0% of flowOrdinary SharesSEC:0001104659-22-124180:0
10 shares@ US$2.23920.0% of flowOrdinary SharesSEC:0001104659-22-116022:0
5 shares@ US$2.540.0% of flowOrdinary SharesSEC:0001104659-22-113574:0
9 shares@ US$2.720.0% of flowOrdinary SharesSEC:0001104659-22-107772:0
5 shares@ US$2.080.0% of flowOrdinary SharesSEC:0001104659-22-106053:0
225 shares@ US$0.15660.0% of flowOrdinary SharesSEC:0001104659-22-098289:0
107 shares@ US$0.16460.0% of flowOrdinary SharesSEC:0001104659-22-097114:0
225 shares@ US$0.18470.0% of flowOrdinary SharesSEC:0001104659-22-087403:0
107 shares@ US$0.1790.0% of flowOrdinary SharesSEC:0001104659-22-085786:0
225 shares@ US$0.18220.0% of flowOrdinary SharesSEC:0001104659-22-078028:0
107 shares@ US$0.1820.0% of flowOrdinary SharesSEC:0001104659-22-076941:0
225 shares@ US$0.200.0% of flowOrdinary SharesSEC:0001104659-22-068985:0
107 shares@ US$0.20660.0% of flowOrdinary SharesSEC:0001104659-22-067620:0
225 shares@ US$0.260.0% of flowOrdinary SharesSEC:0001104659-22-057688:0
107 shares@ US$0.310.0% of flowOrdinary SharesSEC:0001104659-22-055332:0
219 shares@ US$0.410.0% of flowOrdinary SharesSEC:0001104659-22-044220:0
104 shares@ US$0.420.0% of flowOrdinary SharesSEC:0001104659-22-042376:0
263 shares@ US$0.430.0% of flowOrdinary SharesSEC:0001104659-22-031514:0
125 shares@ US$0.450.0% of flowOrdinary SharesSEC:0001104659-22-029492:0
263 shares@ US$0.480.1% of flowOrdinary SharesSEC:0001104659-22-013893:0
25 of 46 declarations
About Schroeder Theodore R
Schroeder Theodore R is a Former Chief Executive Officer and a director of Nabriva Therapeutics plc (XNAS) and Phathom Pharmaceuticals, Inc. (XNAS). He has 46 filings in total, and across the sampled recent filings from 2021-05-04 to 2025-04-16, buy amounts are 98452 EUR and sell amounts are 0 EUR, with the most common transaction nature listed as Retenue fiscale.
